THE FUTURE OF CARDIOVASCULAR DIAGNOSIS, MANAGEMENT AND PROGNOSIS
Cardiovascular diseases (CVDs) have now become the leading cause of mortality in India. A quarter of all mortality is attributable to CVD. Ischemic heart disease and stroke are the predominant causes and are responsible for >80% of CVD deaths. The Global Burden of Disease study estimate of age-standardized CVD death rate of 272 per 100000 population in India is higher than the global average of 235 per 100000 population. Some aspects of the CVD epidemic in India are particular causes of concern, including its accelerated buildup, the early age of disease onset in the population, and the high case fatality rate.

Countering the epidemic requires the development of strategies such as the formulation and effective implementation of evidence-based policy, reinforcement of health systems, and emphasis on prevention, early detection, and treatment with the use of both conventional and INNOVATIVE techniques.


Haemoseis256 3D Vasculography, manufactured in Bengalure, India by Scalene Cybernetics Limited, is a revolutionary non-invasive technique for early detection and management of life threatening cardiovascular diseases.  It provides a detailed analysis of cardiovascular haemodynamics, electrodynamics, pulmonary pathology and renal insufficiency. 

Considered as the future of Cardiovascular Diagnosis, Management and Prognosis, Haemoseis256 brings new and powerful cardiovascular information to the out-patient clinic, emergency rooms, intensive care units, cath labs and operation theatres. With a complete vital haemodynamic picture of the heart and arteries, Haemoseis256 provides unique details of minute deviation in flow patterns, invaluable for accurate monitoring of cardiac functions.

Haemosis provides unique details of minute deviation on flow patterns, invaluable for accurate monitoring of cardiac functions. Haemoseis 3d vasculography scan is a risk free, accurate and cost effective assessment of cardiovascular functions that aids in clinical evaluation, general health screening, monitoring of therapy and medical research. It empowers the doctors with more and unique information of the cardiovascular system, never before possible non-invasively.

Who will benefit from 3D Vasculography?
W  Symptomatic patients above 30 years of age.
W  Asymptomatic patients above 35 years of age who want to know their risk status.
W  High risk patients with a strong family history of:
             * Coronary artery disease (CAD)
             * High blood pressure
             * Diabetes
W  People who are highly stressed or overweight.
W  People who need optimization of medication.
W  People who are unable or do not wish to go for invasive diagnostic procedures.
W  Patients who require a second opinion before going for coronary artery bypass surgery.
W  People who perform physically demanding jobs such as pilots, police, navy & military personnel.
W  Corporate companies needing to assess the health status of their key personnel.

 
 
Haemoseis 3D vasculography is the only technology that can give more than 60 vital cardiovascular parameters; several of them were never before possible non-invasively. The easily understandable graphical presentation of most sought information for early detection leading to early intervention thus aiding in primary prevention of cardiovascular disorders some of which are represented below:
How is 3D Vasculography testing done and how long does it take?

The duration of the test is between 30 to 45 minutes. The patient lies flat on a bed and a system of signal generating and signal receiving electrodes that are attached to cables are strategically placed on the patient's body, together with a highly sensitive Vertical Acceleration Device (VAD). Blood pressure is measured continuously during the test. Trans-Aortic Signal Wave Modulation (TASWM) and Flow Turbulence Accelometry (FTA) are used to reconstruct and transmit over sixty 3 Dimensional real time images and measures. The 23 page data is printed and interpreted before a complete summary report is compiled.

Clinical Applications

¨  Reliable detection of coronary artery disease and its severity.
¨  Early detection of coronary artery disease in asymptomatic patients.
¨  Establish proneness to sudden cardiac death syndrome (SCDS).
¨  Establish cause of chest pains in undiagnosed cardiac patients.
¨  In critical care medicine-for monitoring vital functions non-invasively and drug use to improve prognosis optimizing.
¨  Establishment of fluid overload during dialysis, plasmapheresis.
¨  Early detection of pulmonary oedema, before the development of clinical symptoms.
¨  Establishment of functional effectiveness of drugs and treatment.
¨  Can be used effectively before, during and after procedures like External Counterpulsation (ECP) or Intra-Aortic Balloon Pump (IABP), where measurement of coronary perfusion pressure, coronary blood flow and valvular pliability is important.
¨  An invaluable tool in evaluating the degree of success of Angioplasty, Coronary Artery Stent insertion, Coronary Artery Bypass Grafting (CABG) and Valve Repair surgery.
¨  The only way to follow up neonates where invasive techniques are risky or impossible
¨  Pre-operative assessment of cardio-pulmonary fitness.

 
Approvals & Endorsements

There are currently 150 machines in 20 countries across the world and the numbers are growing as more and more doctors are recognizing the edge it provides as an aid in treating patients.
The Haemoseis256 3D Vasculography device has CE approval which is recognized internationally.

Field of Use:

Haemoseis256 3D Vasculography is used in various fields of medicine.
Though not limited, some popular medical applications are in the fields of:

· Cardiology                                                        
· Neonatology                       
· Anesthesiology                                                        
· Pharmacology                    
· Nephrology                                                        
· Cath Labs                    
· Sports Training Facilities                                                
· Emergency Evacuation Systems
· Critical Care Medicine                                            
· Operating Theatres
· Teaching & Training Medical Students                    
· Drug Testing

 
 
BENEFITS OF HAEMOSEIS 256â

NON INVASIVE
AFFORDABLE
EXTREMELY SAFE
Procedure can be conducted by technicians and be interpreted by doctors after training in Applied Physiology
Dynamic and continuous real time monitoring enables early detection of functional changes and realistic determination of coronary artery patency by measuring myocardial blood flow.
Measures, evaluates and computes more than sixty vital applied physiological parameters (Comprising beat to beat pressure, volume and time changes) in four to five minutes.
Website Designed by Elita India